1
|
Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes. Pharmaceutics 2021; 14:pharmaceutics14010025. [PMID: 35056921 PMCID: PMC8778791 DOI: 10.3390/pharmaceutics14010025] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Revised: 11/29/2021] [Accepted: 12/14/2021] [Indexed: 11/17/2022] Open
Abstract
Aerosol lung gene therapy using non-viral delivery systems represents a credible therapeutic strategy for chronic respiratory diseases, such as cystic fibrosis (CF). Progress in CF clinical setting using the lipidic formulation GL67A has demonstrated the relevance of such a strategy while emphasizing the need for more potent gene transfer agents. In recent years, many novel non-viral gene delivery vehicles were proposed as potential alternatives to GL67 cationic lipid. However, they were usually evaluated using procedures difficult or even impossible to implement in clinical practice. In this study, a clinically-relevant administration protocol via aerosol in murine lungs was used to conduct a comparative study with GL67A. Diverse lipidic compounds were used to prepare a series of formulations inspired by the composition of GL67A. While some of these formulations were ineffective at transfecting murine lungs, others demonstrated modest-to-very-efficient activities and a series of structure-activity relationships were unveiled. Lipidic aminoglycoside derivative-based formulations were found to be at least as efficient as GL67A following aerosol delivery of a luciferase-encoding plasmid DNA. A single aerosol treatment with one such formulation was found to mediate long-term lung transgene expression, exceeding half the animal's lifetime. This study clearly supports the potential of aminoglycoside-based cationic lipids as potent GL67-alternative scaffolds for further enhanced aerosol non-viral lung gene therapy for diseases such as CF.
Collapse
|
2
|
Pennetta C, Bono N, Ponti F, Bellucci MC, Viani F, Candiani G, Volonterio A. Multifunctional Neomycin-Triazine-Based Cationic Lipids for Gene Delivery with Antibacterial Properties. Bioconjug Chem 2021; 32:690-701. [PMID: 33470802 PMCID: PMC8154203 DOI: 10.1021/acs.bioconjchem.0c00616] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
![]()
Cationic
lipids (CLs) have gained significant attention among nonviral
gene delivery vectors due to their ease of synthesis and functionalization
with multivalent moieties. In particular, there is an increasing request
for multifunctional CLs having gene delivery capacity and antibacterial
activity. Herein, we describe the design and synthesis of a novel
class of aminoglycoside (AG)-based multifunctional vectors with high
transfection efficiency and noticeable antibacterial properties. Specifically,
cationic amphiphiles were built on a triazine scaffold, allowing for
an easy derivatization with up to three potentially different substituents,
such as neomycin (Neo) that serves as the polar head and one or two
lipophilic tails, namely stearyl (ST) and oleyl (OL) alkyl chains
and cholesteryl (Chol) tail. With the aim to shed more light on the
effect of different types and numbers of lipophilic moieties on the
ability of CLs to condense and transfect cells, the performance of
Neo–triazine-based derivatives as gene delivery vectors was
evaluated and compared. The ability of Neo–triazine-based derivatives
to act as antimicrobial agents was evaluated as well. Neo–triazine-based
CLs invariably exhibited excellent DNA condensation ability, even
at a low charge ratio (CR, +/−). Besides, each derivative showed
very good transfection performance at its optimal CR on two different
cell lines, along with negligible cytotoxicity. CLs bearing symmetric
two-tailed OL proved to be the most effective in transfection. Interestingly,
Neo–triazine-based derivatives, used as either free lipids
or lipoplexes, exhibited strong antibacterial activity against Gram-negative
bacteria, especially in the case of CLs bearing one or two aliphatic
chains. Altogether, these results highlight the potential of Neo–triazine-based
derivatives as effective multifunctional nonviral gene delivery vectors.
Collapse
Affiliation(s)
- Chiara Pennetta
- Department of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Via Mancinelli 7, Milan 20131, Italy
| | - Nina Bono
- Department of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Via Mancinelli 7, Milan 20131, Italy
| | - Federica Ponti
- Department of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Via Mancinelli 7, Milan 20131, Italy.,Laboratory for Biomaterials and Bioengineering, Canada Research Chair I in Biomaterials and Bioengineering for the Innovation in Surgery, Department of Min-Met-Materials Engineering & Research Center of CHU de Quebec, Division of Regenerative Medicine, Laval University, Quebec City, Quebec G1 V 0A6, Canada
| | - Maria Cristina Bellucci
- Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, Via Celoria 2, Milan 20133, Italy
| | - Fiorenza Viani
- Consiglio Nazionale delle Ricerche, Istituto di Scienze e Tecnologie Chimiche "G. Natta" (SCITEC), Via Mario Bianco 9, Milan 20131, Italy
| | - Gabriele Candiani
- Department of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Via Mancinelli 7, Milan 20131, Italy
| | - Alessandro Volonterio
- Department of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Via Mancinelli 7, Milan 20131, Italy.,Consiglio Nazionale delle Ricerche, Istituto di Scienze e Tecnologie Chimiche "G. Natta" (SCITEC), Via Mario Bianco 9, Milan 20131, Italy
| |
Collapse
|
3
|
Dezanet C, Kempf J, Mingeot-Leclercq MP, Décout JL. Amphiphilic Aminoglycosides as Medicinal Agents. Int J Mol Sci 2020; 21:E7411. [PMID: 33049963 PMCID: PMC7583001 DOI: 10.3390/ijms21197411] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2020] [Revised: 09/27/2020] [Accepted: 10/02/2020] [Indexed: 12/25/2022] Open
Abstract
The conjugation of hydrophobic group(s) to the polycationic hydrophilic core of the antibiotic drugs aminoglycosides (AGs), targeting ribosomal RNA, has led to the development of amphiphilic aminoglycosides (AAGs). These drugs exhibit numerous biological effects, including good antibacterial effects against susceptible and multidrug-resistant bacteria due to the targeting of bacterial membranes. In the first part of this review, we summarize our work in identifying and developing broad-spectrum antibacterial AAGs that constitute a new class of antibiotic agents acting on bacterial membranes. The target-shift strongly improves antibiotic activity against bacterial strains that are resistant to the parent AG drugs and to antibiotic drugs of other classes, and renders the emergence of resistant Pseudomonas aeruginosa strains highly difficult. Structure-activity and structure-eukaryotic cytotoxicity relationships, specificity and barriers that need to be crossed in their development as antibacterial agents are delineated, with a focus on their targets in membranes, lipopolysaccharides (LPS) and cardiolipin (CL), and the corresponding mode of action against Gram-negative bacteria. At the end of the first part, we summarize the other recent advances in the field of antibacterial AAGs, mainly published since 2016, with an emphasis on the emerging AAGs which are made of an AG core conjugated to an adjuvant or an antibiotic drug of another class (antibiotic hybrids). In the second part, we briefly illustrate other biological and biochemical effects of AAGs, i.e., their antifungal activity, their use as delivery vehicles of nucleic acids, of short peptide (polyamide) nucleic acids (PNAs) and of drugs, as well as their ability to cleave DNA at abasic sites and to inhibit the functioning of connexin hemichannels. Finally, we discuss some aspects of structure-activity relationships in order to explain and improve the target selectivity of AAGs.
Collapse
Affiliation(s)
- Clément Dezanet
- Molecular Pharmacochemistry Department, University Grenoble Alpes, CNRS, 470 Rue de la Chimie, F-38000 Grenoble, France; (C.D.); (J.K.)
| | - Julie Kempf
- Molecular Pharmacochemistry Department, University Grenoble Alpes, CNRS, 470 Rue de la Chimie, F-38000 Grenoble, France; (C.D.); (J.K.)
| | - Marie-Paule Mingeot-Leclercq
- Cellular and Molecular Pharmacology Unit, Louvain Drug Research Institute, Catholic University of Louvain, Avenue E. Mounier 73, UCL B1.73.05, 1200 Brussels, Belgium
| | - Jean-Luc Décout
- Molecular Pharmacochemistry Department, University Grenoble Alpes, CNRS, 470 Rue de la Chimie, F-38000 Grenoble, France; (C.D.); (J.K.)
| |
Collapse
|
4
|
Bellucci MC, Volonterio A. Aminoglycosides: From Antibiotics to Building Blocks for the Synthesis and Development of Gene Delivery Vehicles. Antibiotics (Basel) 2020; 9:E504. [PMID: 32796727 PMCID: PMC7459817 DOI: 10.3390/antibiotics9080504] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Revised: 07/29/2020] [Accepted: 08/07/2020] [Indexed: 02/06/2023] Open
Abstract
Aminoglycosides are a class of naturally occurring and semi synthetic antibiotics that have been used for a long time in fighting bacterial infections. Due to acquired antibiotic resistance and inherent toxicity, aminoglycosides have experienced a decrease in interest over time. However, in the last decade, we are seeing a renaissance of aminoglycosides thanks to a better understanding of their chemistry and mode of action, which had led to new trends of application. The purpose of this comprehensive review is to highlight one of these new fields of application: the use of aminoglycosides as building blocks for the development of liposomal and polymeric vectors for gene delivery. The design, synthetic strategies, ability to condensate the genetic material, the efficiency in transfection, and cytotoxicity as well as when available, the antibacterial activity of aminoglycoside-based cationic lipids and polymers are covered and critically analyzed.
Collapse
Affiliation(s)
- Maria Cristina Bellucci
- Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, via Celoria 2, 20133 Milano, Italy;
| | - Alessandro Volonterio
- Department of Chemistry, Material and Chemical Engineer “Giulio Natta”, Politecnico di Milano, via Mancinelli 7, 20131 Milano, Italy
| |
Collapse
|
5
|
Bono N, Pennetta C, Sganappa A, Giupponi E, Sansone F, Volonterio A, Candiani G. Design and synthesis of biologically active cationic amphiphiles built on the calix[4]arene scaffold. Int J Pharm 2018; 549:436-445. [DOI: 10.1016/j.ijpharm.2018.08.020] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2018] [Revised: 07/27/2018] [Accepted: 08/13/2018] [Indexed: 12/14/2022]
|
6
|
Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties. Biosci Rep 2017; 37:BSR20160618. [PMID: 29046368 PMCID: PMC5691145 DOI: 10.1042/bsr20160618] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2017] [Revised: 10/09/2017] [Accepted: 10/10/2017] [Indexed: 02/06/2023] Open
Abstract
The pathophysiology of obstructive pulmonary diseases, such as cystic fibrosis (CF), leads to the development of chronic infections in the respiratory tract. Thus, the symptomatic management of the disease requires, in particular, repetitive antibiotherapy. Besides these antibacterial treatments, certain pathologies, such as CF or chronic obstructive pulmonary disease (COPD), require the intake of many drugs. This simultaneous absorption may lead to undesirable drug interactions. For example, Orkambi® (lumacaftor/Ivacaftor, Vertex), a pharmacological drug employed to treat F508del patients, cannot be used with antibiotics such as rifampicin or rifabutin (rifamycin family) which are necessary to treat Mycobacteriaceae. As far as gene therapy is concerned, bacteria and/or biofilm in the airways present an additional barrier for gene transfer. Thus, aerosol administration of nanoparticles have to overcome many obstacles before allowing cellular penetration of therapeutic compounds. This review focusses on the development of aerosol formulations adapted to the respiratory tract and its multiple barriers. Then, formulations that are currently used in clinical applications are summarized depending on the active molecule delivered. Finally, we focus on new therapeutic approaches to reduce possible drug interactions by transferring the antibacterial activity to the nanocarrier while ensuring the transfection efficiency.
Collapse
|
7
|
Zimmermann L, Das I, Désiré J, Sautrey G, Barros R. S. V, El Khoury M, Mingeot-Leclercq MP, Décout JL. New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues. J Med Chem 2016; 59:9350-9369. [DOI: 10.1021/acs.jmedchem.6b00818] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Affiliation(s)
- Louis Zimmermann
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Indrajit Das
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Jérôme Désiré
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Guillaume Sautrey
- Unité
de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research
Institute, Université Catholique de Louvain, Avenue E.
Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Vinicius Barros R. S.
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Micheline El Khoury
- Unité
de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research
Institute, Université Catholique de Louvain, Avenue E.
Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Marie-Paule Mingeot-Leclercq
- Unité
de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research
Institute, Université Catholique de Louvain, Avenue E.
Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Jean-Luc Décout
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| |
Collapse
|
8
|
Gosangi M, Mujahid TY, Gopal V, Patri SV. Effects of heterocyclic-based head group modifications on the structure–activity relationship of tocopherol-based lipids for non-viral gene delivery. Org Biomol Chem 2016; 14:6857-70. [DOI: 10.1039/c6ob00974c] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Gene therapy, a promising strategy for the delivery of therapeutic nucleic acids, is greatly dependent on the development of efficient vectors.
Collapse
Affiliation(s)
| | | | - Vijaya Gopal
- CSIR-Centre for Cellular and Molecular Biology
- Hyderabad-500007
- India
| | | |
Collapse
|
9
|
Mingeot-Leclercq MP, Décout JL. Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside antibiotics and emergence of amphiphilic aminoglycosides. MEDCHEMCOMM 2016. [DOI: 10.1039/c5md00503e] [Citation(s) in RCA: 97] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Membrane anionic lipids as attractive targets in the design of amphiphilic antibacterial drugs active against resistant bacteria: molecular foundations and examples.
Collapse
Affiliation(s)
- Marie-Paule Mingeot-Leclercq
- Louvain Drug Research Institute
- Université catholique de Louvain
- Unité de Pharmacologie Cellulaire et Moléculaire
- Brussels
- Belgium
| | - Jean-Luc Décout
- Département de Pharmacochimie Moléculaire
- Université Grenoble Alpes/CNRS
- UMR 5063
- ICMG FR 2607
- F-38041 Grenoble
| |
Collapse
|
10
|
Le Gall T, Barbeau J, Barrier S, Berchel M, Lemiègre L, Jeftić J, Meriadec C, Artzner F, Gill DR, Hyde SC, Férec C, Lehn P, Jaffrès PA, Benvegnu T, Montier T. Effects of a Novel Archaeal Tetraether-Based Colipid on the In Vivo Gene Transfer Activity of Two Cationic Amphiphiles. Mol Pharm 2014; 11:2973-88. [DOI: 10.1021/mp4006276] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Tony Le Gall
- Unité
INSERM 1078, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, 46 rue Félix Le Dantec, CS51819, 29218 Brest Cedex 02, France
- Plateforme
SynNanoVect, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, Brest, France
| | - Julie Barbeau
- Ecole
Nationale Supérieure de Chimie de Rennes, Université Européenne de Bretagne, CNRS,
UMR 6226, 11 allée de Beaulieu,
CS 50837, 35708 Rennes Cedex 7, France
| | - Sylvain Barrier
- Ecole
Nationale Supérieure de Chimie de Rennes, Université Européenne de Bretagne, CNRS,
UMR 6226, 11 allée de Beaulieu,
CS 50837, 35708 Rennes Cedex 7, France
| | - Mathieu Berchel
- CEMCA,
CNRS UMR 6521, SFR ScInBioS, Université Européenne de Bretagne, Université de Brest, Brest, France
| | - Loïc Lemiègre
- Plateforme
SynNanoVect, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, Brest, France
- Ecole
Nationale Supérieure de Chimie de Rennes, Université Européenne de Bretagne, CNRS,
UMR 6226, 11 allée de Beaulieu,
CS 50837, 35708 Rennes Cedex 7, France
| | - Jelena Jeftić
- Plateforme
SynNanoVect, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, Brest, France
- Ecole
Nationale Supérieure de Chimie de Rennes, Université Européenne de Bretagne, CNRS,
UMR 6226, 11 allée de Beaulieu,
CS 50837, 35708 Rennes Cedex 7, France
| | - Cristelle Meriadec
- Institut
de Physique de Rennes, Université Européenne de Bretagne, Université de Rennes 1, UMR-CNRS 6251, Campus Beaulieu Bat.
11A, 35042 Rennes
Cedex, France
| | - Franck Artzner
- Institut
de Physique de Rennes, Université Européenne de Bretagne, Université de Rennes 1, UMR-CNRS 6251, Campus Beaulieu Bat.
11A, 35042 Rennes
Cedex, France
| | - Deborah R. Gill
- Gene Medicine
Group, Nuffield Division of Clinical Laboratory Sciences, University of Oxford,
John Radcliffe Hospital, Oxford, United Kingdom
| | - Stephen C. Hyde
- Gene Medicine
Group, Nuffield Division of Clinical Laboratory Sciences, University of Oxford,
John Radcliffe Hospital, Oxford, United Kingdom
| | - Claude Férec
- Unité
INSERM 1078, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, 46 rue Félix Le Dantec, CS51819, 29218 Brest Cedex 02, France
| | - Pierre Lehn
- Unité
INSERM 1078, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, 46 rue Félix Le Dantec, CS51819, 29218 Brest Cedex 02, France
| | - Paul-Alain Jaffrès
- Plateforme
SynNanoVect, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, Brest, France
- CEMCA,
CNRS UMR 6521, SFR ScInBioS, Université Européenne de Bretagne, Université de Brest, Brest, France
| | - Thierry Benvegnu
- Plateforme
SynNanoVect, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, Brest, France
- Ecole
Nationale Supérieure de Chimie de Rennes, Université Européenne de Bretagne, CNRS,
UMR 6226, 11 allée de Beaulieu,
CS 50837, 35708 Rennes Cedex 7, France
| | - Tristan Montier
- Unité
INSERM 1078, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, 46 rue Félix Le Dantec, CS51819, 29218 Brest Cedex 02, France
- Plateforme
SynNanoVect, SFR ScInBioS; Université de Bretagne Occidentale, Université Européenne de Bretagne, Brest, France
| |
Collapse
|
11
|
Ghilardi A, Pezzoli D, Bellucci MC, Malloggi C, Negri A, Sganappa A, Tedeschi G, Candiani G, Volonterio A. Synthesis of Multifunctional PAMAM–Aminoglycoside Conjugates with Enhanced Transfection Efficiency. Bioconjug Chem 2013; 24:1928-36. [DOI: 10.1021/bc4003635] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Alessandra Ghilardi
- Department
of Chemistry, Materials, and Chemical Engineering “G. Natta”, Politecnico di Milano, via Mancinelli 7, 20131 Milano, Italy
| | - Daniele Pezzoli
- Politecnico
di Milano Research Unit, National Interuniversity Consortium of Materials Science and Technology - INSTM, via Mancinelli 7, 20131 Milano, Italy
| | - Maria Cristina Bellucci
- Department
of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, via Celoria 2, 20133 Milano, Italy
| | - Chiara Malloggi
- Department
of Chemistry, Materials, and Chemical Engineering “G. Natta”, Politecnico di Milano, via Mancinelli 7, 20131 Milano, Italy
| | - Armando Negri
- Department
of Veterinary Science and Public Health, Università degli Studi di Milano, via Celoria 10, 20133 Milano, Italy
| | - Aurora Sganappa
- Department
of Chemistry, Materials, and Chemical Engineering “G. Natta”, Politecnico di Milano, via Mancinelli 7, 20131 Milano, Italy
| | - Gabriella Tedeschi
- Department
of Veterinary Science and Public Health, Università degli Studi di Milano, via Celoria 10, 20133 Milano, Italy
| | - Gabriele Candiani
- Department
of Chemistry, Materials, and Chemical Engineering “G. Natta”, Politecnico di Milano, via Mancinelli 7, 20131 Milano, Italy
- Politecnico
di Milano Research Unit, National Interuniversity Consortium of Materials Science and Technology - INSTM, via Mancinelli 7, 20131 Milano, Italy
| | - Alessandro Volonterio
- Department
of Chemistry, Materials, and Chemical Engineering “G. Natta”, Politecnico di Milano, via Mancinelli 7, 20131 Milano, Italy
| |
Collapse
|
12
|
Le Gall T, Berchel M, Le Hir S, Fraix A, Salaün JY, Férec C, Lehn P, Jaffrès PA, Montier T. Arsonium-containing lipophosphoramides, poly-functional nano-carriers for simultaneous antibacterial action and eukaryotic cell transfection. Adv Healthc Mater 2013; 2:1513-24. [PMID: 23625809 DOI: 10.1002/adhm.201200478] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2012] [Indexed: 01/05/2023]
Abstract
Gene therapy of diseases like cystic fibrosis (CF) would consist of delivering a gene medicine towards the lungs via the respiratory tract into the target epithelial cells. Accordingly, poly-functional nano-carriers are required in order to overcome the various successive barriers of such a complex environment, such as airway colonization with bacterial strains. In this work, the antibacterial effectiveness of a series of cationic lipids is investigated before evaluating its compatibility with gene transfer into human bronchial epithelial cells. Among the various compounds considered, some bearing a trimethyl-arsonium headgroup demonstrate very potent biocide effects towards clinically relevant bacterial strains. In contrast to cationic lipids exhibiting no or insufficient antibacterial potency, arsonium-containing lipophosphoramides can simultaneously inhibit bacteria while delivering DNA into eukaryotic cells, as efficiently and safely as in absence of bacteria. Moreover, such vectors can demonstrate antibacterial activity in vitro while retaining high gene transfection efficiency to the nasal epithelium as well as to the lungs in mice in vivo. Arsonium-containing amphiphiles are the first synthetic compounds shown to achieve efficient gene delivery in the presence of bacteria, a property particularly suitable for gene therapy strategies under infected conditions such as within the airways of CF patients.
Collapse
Affiliation(s)
- Tony Le Gall
- Unité INSERM 1078; SFR ScInBioS, Université de Bretagne Occidentale, Université Européenne de Bretagne, Faculté de Médecine et des Sciences de la Santé, 22 avenue Camille Desmoulins, 29238 Brest, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Perigolo de Oliveira M, Constant JF, Peuchmaur M, Pitta I, Décout JL. Antibiotic drugs aminoglycosides cleave DNA at abasic sites: shedding new light on their toxicity? Chem Res Toxicol 2013; 26:1710-9. [PMID: 24127848 DOI: 10.1021/tx4002836] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Abasic sites are probably the most common lesions in DNA resulting from the hydrolytic cleavage of glycosidic bonds that can occur spontaneously and through DNA alkylation by anticancer agents, by radiotherapy, and during the repair processes of damaged nucleic bases. If not repaired, the abasic site can be mutagenic or lethal. Thus, compounds able to specifically bind and react at abasic sites have attracted much attention for therapeutic and diagnostic purposes. Here, we report on the efficient cleavage activity of characteristic antibiotic drugs of the major aminoglycosides (AG) family at abasic sites introduced either by depurination in a plasmidic DNA or site specifically in a synthetic oligonucleotide. Among the antibiotic AG drugs selected for this study, neomycin B is the most efficient (a 0.1 μM concentration induces 50% cleavage of an abasic site containing DNA). This cleavage activity could be related to aminoglycoside toxicity but also find medicinal applications through potentiation of cancer radiotherapy and chemotherapy with alkylating drugs. In the search for antibiotic and antiviral agents, we have previously described the synthesis of derivatives of the small aminoglycoside neamine, which corresponds to rings I and II of neomycin B constituted of four rings. The cleavage activity at abasic sites of four of these neamine derivatives is also reported in the present study. One of them appeared to be much more active than the parent compound neamine with cleavage efficiency close to that of neomycin.
Collapse
Affiliation(s)
- Maralise Perigolo de Oliveira
- UMR 5063, Département de Pharmacochimie Moléculaire, ICMG FR 2607, Université de Grenoble I/CNRS , 470 rue de la Chimie, BP 53, F-38041 Grenoble, France
| | | | | | | | | |
Collapse
|
14
|
Zimmermann L, Bussière A, Ouberai M, Baussanne I, Jolivalt C, Mingeot-Leclercq MP, Décout JL. Tuning the Antibacterial Activity of Amphiphilic Neamine Derivatives and Comparison to Paromamine Homologues. J Med Chem 2013; 56:7691-705. [DOI: 10.1021/jm401148j] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Affiliation(s)
- Louis Zimmermann
- Département
de Pharmacochimie Moléculaire, Université de Grenoble I/CNRS, UMR 5063, ICMG FR
2607, 470 rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Antoine Bussière
- Département
de Pharmacochimie Moléculaire, Université de Grenoble I/CNRS, UMR 5063, ICMG FR
2607, 470 rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Myriam Ouberai
- Unité de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Isabelle Baussanne
- Département
de Pharmacochimie Moléculaire, Université de Grenoble I/CNRS, UMR 5063, ICMG FR
2607, 470 rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Claude Jolivalt
- Ecole Nationale de Chimie de Paris/CNRS, UMR
7573, 11 rue Pierre et Marie Curie, F-75231 Paris cedex 05, France
| | - Marie-Paule Mingeot-Leclercq
- Unité de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Jean-Luc Décout
- Département
de Pharmacochimie Moléculaire, Université de Grenoble I/CNRS, UMR 5063, ICMG FR
2607, 470 rue de la Chimie, BP 53, F-38041 Grenoble, France
| |
Collapse
|
15
|
Zhi D, Zhang S, Cui S, Zhao Y, Wang Y, Zhao D. The Headgroup Evolution of Cationic Lipids for Gene Delivery. Bioconjug Chem 2013; 24:487-519. [DOI: 10.1021/bc300381s] [Citation(s) in RCA: 188] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Affiliation(s)
- Defu Zhi
- State Key Laboratory of Fine
Chemicals, Dalian University of Technology, Dalian 116012, China
- State Ethnic Affairs Commission-Ministry
of Education Key Laboratory of Biotechnology and Bio-resources Utilization, Dalian Nationalities University, Dalian 116600, China
| | - Shubiao Zhang
- State Ethnic Affairs Commission-Ministry
of Education Key Laboratory of Biotechnology and Bio-resources Utilization, Dalian Nationalities University, Dalian 116600, China
| | - Shaohui Cui
- State Ethnic Affairs Commission-Ministry
of Education Key Laboratory of Biotechnology and Bio-resources Utilization, Dalian Nationalities University, Dalian 116600, China
| | - Yinan Zhao
- State Ethnic Affairs Commission-Ministry
of Education Key Laboratory of Biotechnology and Bio-resources Utilization, Dalian Nationalities University, Dalian 116600, China
| | | | - Defeng Zhao
- State Key Laboratory of Fine
Chemicals, Dalian University of Technology, Dalian 116012, China
| |
Collapse
|
16
|
Loizeau D, Le Gall T, Mahfoudhi S, Berchel M, Maroto A, Yaouanc JJ, Jaffrès PA, Lehn P, Deschamps L, Montier T, Giamarchi P. Physicochemical properties of cationic lipophosphoramidates with an arsonium head group and various lipid chains: A structure–activity approach. Biophys Chem 2013. [DOI: 10.1016/j.bpc.2012.10.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
17
|
Das I, Désiré J, Manvar D, Baussanne I, Pandey VN, Décout JL. A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription. J Med Chem 2012; 55:6021-32. [PMID: 22698070 PMCID: PMC3400927 DOI: 10.1021/jm300253q] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
The 6-aminoglucosamine ring of the aminoglycoside antibiotic neomycin B (ring II) was conjugated to a 16-mer peptide nucleic acid (PNA) targeting HIV-1 TAR RNA. For this purpose, we prepared the aminoglucosamine monomer 15 and attached it to the protected PNA prior to its cleavage from the solid support. We found that the resulting PNA-aminoglucosamine conjugate is stable under acidic conditions, efficiently taken up by the human cells and fairly distributed in both cytosol and nucleus without endosomal entrapment because cotreatment with endosome-disrupting agent had no effect on its cellular distribution. The conjugate displayed very high target specificity in vitro and strongly inhibited Tat mediated transactivation of HIV-1 LTR transcription in a cell culture system. The unique properties of this new class of PNA conjugate suggest it to be a potential candidate for therapeutic application.
Collapse
Affiliation(s)
- Indrajit Das
- Université de Grenoble I/CNRS, UMR 5063, Département de Pharmacochimie Moléculaire, ICMG FR 2607, 470 rue de la Chimie BP 53 F-38041 Grenoble, France
| | - Jérôme Désiré
- Université de Grenoble I/CNRS, UMR 5063, Département de Pharmacochimie Moléculaire, ICMG FR 2607, 470 rue de la Chimie BP 53 F-38041 Grenoble, France
| | - Dinesh Manvar
- Center for the Study of Emerging and Re-emerging Pathogens, UMDNJ-New Jersey Medical School, Department of Biochemistry and Molecular Biology, 185 South Orange Avenue, Newark, New Jersey 07103, USA
| | - Isabelle Baussanne
- Université de Grenoble I/CNRS, UMR 5063, Département de Pharmacochimie Moléculaire, ICMG FR 2607, 470 rue de la Chimie BP 53 F-38041 Grenoble, France
| | - Virendra N. Pandey
- Center for the Study of Emerging and Re-emerging Pathogens, UMDNJ-New Jersey Medical School, Department of Biochemistry and Molecular Biology, 185 South Orange Avenue, Newark, New Jersey 07103, USA
| | - Jean-Luc Décout
- Université de Grenoble I/CNRS, UMR 5063, Département de Pharmacochimie Moléculaire, ICMG FR 2607, 470 rue de la Chimie BP 53 F-38041 Grenoble, France
| |
Collapse
|
18
|
Jackowski O, Bussière A, Vanhaverbeke C, Baussanne I, Peyrin E, Mingeot-Leclercq MP, Décout JL. Major increases of the reactivity and selectivity in aminoglycoside O-alkylation due to the presence of fluoride ions. Tetrahedron 2012. [DOI: 10.1016/j.tet.2011.10.102] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
19
|
Bera S, Zhanel GG, Schweizer F. Synthesis and antibacterial activity of amphiphilic lysine-ligated neomycin B conjugates. Carbohydr Res 2011; 346:560-8. [PMID: 21353205 DOI: 10.1016/j.carres.2011.01.015] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2010] [Revised: 01/13/2011] [Accepted: 01/14/2011] [Indexed: 11/19/2022]
Abstract
Amphiphilic lysine-ligated neomycin B building blocks were prepared by reductive amination of a protected C5″-modified neomycin B-based aldehyde and side chain-unprotected lysine or lysine-containing peptides. It was demonstrated that a suitably protected lysine-ligated neomycin B conjugate (NeoK) serves as a building block for peptide synthesis, enabling incorporation of aminoglycoside binding sites into peptides. Antibacterial testing of three amphiphilic lysine-ligated neomycin B conjugates against a representative panel of Gram-positive and Gram-negative strains demonstrates that C5″-modified neomycin-lysine conjugate retains antibacterial activity. However, in most cases the lysine-ligated neomycin B analogs display reduced potency against Gram-positive strains when compared to unmodified neomycin B or unligated peptide. An exception is MRSA where an eightfold enhancement was observed. When compared to unmodified neomycin B, the prepared lysine-neomycin conjugates exhibited a 4-8-fold enhanced Gram-negative activity against Pseudomonas aeruginosa and up to 12-fold enhanced activity was observed when compared to unligated reference peptides.
Collapse
Affiliation(s)
- Smritilekha Bera
- Department of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N2
| | | | | |
Collapse
|
20
|
Le Gall T, Loizeau D, Picquet E, Carmoy N, Yaouanc JJ, Burel-Deschamps L, Delépine P, Giamarchi P, Jaffrès PA, Lehn P, Montier T. A Novel Cationic Lipophosphoramide with Diunsaturated Lipid Chains: Synthesis, Physicochemical Properties, and Transfection Activities. J Med Chem 2010; 53:1496-508. [DOI: 10.1021/jm900897a] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
| | - Damien Loizeau
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | - Erwan Picquet
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | | | - Jean-Jacques Yaouanc
- IBiSA SynNanoVect platform
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | - Laure Burel-Deschamps
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | | | - Philippe Giamarchi
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | - Paul-Alain Jaffrès
- IBiSA SynNanoVect platform
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | | | | |
Collapse
|